IL1B and neoplasm: The results indicated that expressions of caspase-1, IL-1β, and IL-18 were downregulated in tumor samples and that simvastatin determined the decrease of tumor cell viability directly proportional to the dose administered, thus decreasing lung cancer cell proliferation and migration via pyroptosis initiation.